AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Join the community
Most Read
1. Mitsui Sumitomo Insurance targets Chinese nationals in Thailand 2. What will drive Singapore to double its stock market value by 2030? 3. 1 in 2 Singaporeans say communication is excellent amongst insurers 4. 7MM sarcopenia market to see 8.1% CAGR growth until 2034 5. Why 6 in 10 Gen Zs don’t feel financially secureResource Center
Awards
Sep
25
Sep
25
Event News
Co-Written / Partner
Showcase your groundbreaking innovations at the inaugural Asian Innovation Excellence Awards
Be recognised amongst the region's finest innovators.
Commentary
Mobile-first web design: Why Asian brands can't afford to ignore it in 2025